Page last updated: 2024-09-03

dehydroevodiamine and calyculin a

dehydroevodiamine has been researched along with calyculin a in 1 studies

Compound Research Comparison

Studies
(dehydroevodiamine)
Trials
(dehydroevodiamine)
Recent Studies (post-2010)
(dehydroevodiamine)
Studies
(calyculin a)
Trials
(calyculin a)
Recent Studies (post-2010) (calyculin a)
481189150110

Protein Interaction Comparison

ProteinTaxonomydehydroevodiamine (IC50)calyculin a (IC50)
Tyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)0.0009
Serine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)0.0182
Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B Gallus gallus (chicken)0.0032

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, FY; Fang, J; Hong, XP; Liu, R; Pan, XP; Tian, Q; Wang, JZ; Wang, SH1

Other Studies

1 other study(ies) available for dehydroevodiamine and calyculin a

ArticleYear
Dehydroevodiamine attenuates calyculin A-induced tau hyperphosphorylation in rat brain slices.
    Acta pharmacologica Sinica, 2007, Volume: 28, Issue:11

    Topics: Alkaloids; Animals; In Vitro Techniques; Male; Marine Toxins; Oxazoles; Phosphorylation; Prosencephalon; Protein Phosphatase 1; Protein Phosphatase 2; Rats; Rats, Sprague-Dawley; tau Proteins; Tyrosine

2007